Technical Analysis for RAPP - Rapport Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 20.95 | -4.69% | -1.03 |
RAPP closed down 4.69 percent on Friday, November 15, 2024, on 60 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Doji - Bullish? | Reversal | -4.69% | |
Lower Bollinger Band Walk | Weakness | -4.69% | |
Stochastic Reached Oversold | Weakness | -4.69% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | 1 day ago |
Down 5% | 1 day ago |
Outside Day | 1 day ago |
Fell Below Previous Day's Low | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Central Nervous System Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Central Nervous System Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 29.74 |
52 Week Low | 16.55 |
Average Volume | 143,828 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 22.57 |
20-Day Moving Average | 24.69 |
10-Day Moving Average | 24.23 |
Average True Range | 2.04 |
RSI (14) | 40.12 |
ADX | 16.23 |
+DI | 21.14 |
-DI | 31.86 |
Chandelier Exit (Long, 3 ATRs) | 23.35 |
Chandelier Exit (Short, 3 ATRs) | 26.33 |
Upper Bollinger Bands | 28.06 |
Lower Bollinger Band | 21.32 |
Percent B (%b) | -0.06 |
BandWidth | 27.28 |
MACD Line | -0.07 |
MACD Signal Line | 0.56 |
MACD Histogram | -0.6345 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 24.55 | ||||
Resistance 3 (R3) | 24.70 | 23.65 | 23.95 | ||
Resistance 2 (R2) | 23.65 | 22.73 | 23.58 | 23.75 | |
Resistance 1 (R1) | 22.30 | 22.17 | 21.78 | 22.15 | 23.55 |
Pivot Point | 21.25 | 21.25 | 20.99 | 21.18 | 21.25 |
Support 1 (S1) | 19.90 | 20.33 | 19.38 | 19.75 | 18.35 |
Support 2 (S2) | 18.85 | 19.77 | 18.78 | 18.15 | |
Support 3 (S3) | 17.50 | 18.85 | 17.95 | ||
Support 4 (S4) | 17.35 |